Detalhe da pesquisa
1.
A plain language summary of the TROPHY-U-01 study: sacituzumab govitecan use in people with locally advanced or metastatic urothelial cancer.
Future Oncol
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38682560
2.
Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3.
J Clin Oncol
; 42(12): 1415-1425, 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38261969